Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NAMSA
MedTech
WuXi AppTec sells US device testing business to NAMSA
The deal includes facilities in Atlanta, Georgia and St. Paul, Minnesota; the financial details were not disclosed.
Conor Hale
Jan 17, 2025 10:42am
NAMSA acquires Clinical Research Institute for undisclosed price
Jul 19, 2023 10:50am
NAMSA buys Spain's AKRN Scientific Consulting
Mar 23, 2022 8:35am
Busy week for CRO deals as Inotiv, CenExel tack on new buys
Aug 4, 2021 3:45pm
Device-focused CRO NAMSA buys Clinlogix for 3rd deal of 2021
Aug 4, 2021 12:21pm